| Year |
Citation |
Score |
| 2020 |
Holman SP, Lobo AS, Novorolsky RJ, Nichols M, Fiander MDJ, Konda P, Kennedy BE, Gujar S, Robertson GS. Neuronal mitochondrial calcium uniporter deficiency exacerbates axonal injury and suppresses remyelination in mice subjected to experimental autoimmune encephalomyelitis. Experimental Neurology. 333: 113430. PMID 32745471 DOI: 10.1016/J.Expneurol.2020.113430 |
0.319 |
|
| 2020 |
Novorolsky RJ, Nichols M, Kim JS, Pavlov EV, J Woods J, Wilson JJ, Robertson GS. The cell-permeable mitochondrial calcium uniporter inhibitor Ru265 preserves cortical neuron respiration after lethal oxygen glucose deprivation and reduces hypoxic/ischemic brain injury. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X20908523. PMID 32126877 DOI: 10.1177/0271678X20908523 |
0.301 |
|
| 2019 |
Lamport AC, Chedrawe M, Nichols M, Robertson GS. Experimental autoimmune encephalomyelitis accelerates remyelination after lysophosphatidylcholine-induced demyelination in the corpus callosum. Journal of Neuroimmunology. 334: 576995. PMID 31228686 DOI: 10.1016/J.Jneuroim.2019.576995 |
0.325 |
|
| 2019 |
Ploughman M, Eskes GA, Kelly LP, Kirkland MC, Devasahayam AJ, Wallack EM, Abraha B, Hasan SMM, Downer MB, Keeler L, Wilson G, Skene E, Sharma I, Chaves AR, Curtis ME, ... ... Robertson GS, et al. Synergistic Benefits of Combined Aerobic and Cognitive Training on Fluid Intelligence and the Role of IGF-1 in Chronic Stroke. Neurorehabilitation and Neural Repair. 1545968319832605. PMID 30816066 DOI: 10.1177/1545968319832605 |
0.658 |
|
| 2018 |
Chedrawe MAJ, Holman SP, Lamport AC, Akay T, Robertson GS. Pioglitazone is superior to quetiapine, clozapine and tamoxifen at alleviating experimental autoimmune encephalomyelitis in mice. Journal of Neuroimmunology. 321: 72-82. PMID 29957391 DOI: 10.1016/J.Jneuroim.2018.06.001 |
0.349 |
|
| 2018 |
Nichols M, Pavlov EV, Robertson GS. Tamoxifen-induced knockdown of the mitochondrial calcium uniporter in Thy1-expressing neurons protects mice from hypoxic/ischemic brain injury. Cell Death & Disease. 9: 606. PMID 29789575 DOI: 10.1038/S41419-018-0607-9 |
0.361 |
|
| 2016 |
Nichols M, Elustondo PA, Warford J, Thirumaran A, Pavlov EV, Robertson GS. Global ablation of the mitochondrial calcium uniporter increases glycolysis in cortical neurons subjected to energetic stressors. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 27909264 DOI: 10.1177/0271678X16682250 |
0.331 |
|
| 2015 |
Jie H, Tao S, Liu L, Xia L, Charko A, Yu Z, Bance M, Yin S, Robertson GS, Wang J. Cochlear protection against cisplatin by viral transfection of X-linked inhibitor of apoptosis protein across round window membrane. Gene Therapy. 22: 546-52. PMID 25809464 DOI: 10.1038/Gt.2015.22 |
0.382 |
|
| 2014 |
Ruan Q, Zeng S, Liu A, Chen Z, Yu Z, Zhang R, He J, Bance M, Robertson G, Yin S, Wang J. Overexpression of X-Linked Inhibitor of Apoptotic Protein (XIAP) reduces age-related neuronal degeneration in the mouse cochlea. Gene Therapy. 21: 967-74. PMID 25142138 DOI: 10.1038/Gt.2014.77 |
0.353 |
|
| 2014 |
Laprairie RB, Warford JR, Hutchings S, Robertson GS, Kelly ME, Denovan-Wright EM. The cytokine and endocannabinoid systems are co-regulated by NF-κB p65/RelA in cell culture and transgenic mouse models of Huntington's disease and in striatal tissue from Huntington's disease patients. Journal of Neuroimmunology. 267: 61-72. PMID 24360910 DOI: 10.1016/J.Jneuroim.2013.12.008 |
0.302 |
|
| 2013 |
Grant J, Parker K, Moore CS, Keddy PG, Mayne M, Robertson GS. Over-expression of X-linked inhibitor of apoptosis protein modulates multiple aspects of neuronal Ca2+ signaling. Neurochemical Research. 38: 847-56. PMID 23397285 DOI: 10.1007/S11064-013-0989-0 |
0.717 |
|
| 2012 |
Keddy PG, Dunlop K, Warford J, Samson ML, Jones QR, Rupasinghe HP, Robertson GS. Neuroprotective and anti-inflammatory effects of the flavonoid-enriched fraction AF4 in a mouse model of hypoxic-ischemic brain injury. Plos One. 7: e51324. PMID 23251498 DOI: 10.1371/Journal.Pone.0051324 |
0.38 |
|
| 2012 |
Ji X, Rivers L, Zielinski Z, Xu M, MacDougall E, Stephen J, Zhang S, Wang Y, Chapman RG, Keddy P, Robertson GS, Kirby CW, Embleton J, Worrall K, Murphy A, et al. Quantitative analysis of phenolic components and glycoalkaloids from 20 potato clones and in vitro evaluation of antioxidant, cholesterol uptake, and neuroprotective activities Food Chemistry. 133: 1177-1187. DOI: 10.1016/J.Foodchem.2011.08.065 |
0.305 |
|
| 2011 |
Warford J, Robertson GS. New methods for multiple sclerosis drug discovery. Expert Opinion On Drug Discovery. 6: 689-99. PMID 22650977 DOI: 10.1517/17460441.2011.573783 |
0.359 |
|
| 2011 |
Crocker CE, Khan S, Cameron MD, Robertson HA, Robertson GS, Lograsso P. JNK Inhibition Protects Dopamine Neurons and Provides Behavioral Improvement in a Rat 6-hydroxydopamine Model of Parkinson's Disease. Acs Chemical Neuroscience. 2: 207-212. PMID 21666838 DOI: 10.1021/Cn1001107 |
0.596 |
|
| 2011 |
Wang J, Tymczyszyn N, Yu Z, Yin S, Bance M, Robertson GS. Overexpression of X-linked inhibitor of apoptosis protein protects against noise-induced hearing loss in mice. Gene Therapy. 18: 560-8. PMID 21228883 DOI: 10.1038/Gt.2010.172 |
0.323 |
|
| 2010 |
Hebb AL, Moore CS, Bhan V, Robertson GS. Effects of IFN-B on TRAIL and Decoy Receptor Expression in Different Immune Cell Populations from MS Patients with Distinct Disease Subtypes. Autoimmune Diseases. 2011: 485752. PMID 21253524 DOI: 10.4061/2011/485752 |
0.723 |
|
| 2010 |
Hebb AL, Bhan V, Wishart AD, Moore CS, Robertson GS. Human kallikrein 6 cerebrospinal levels are elevated in multiple sclerosis. Current Drug Discovery Technologies. 7: 137-40. PMID 20836755 DOI: 10.2174/157016310793180611 |
0.697 |
|
| 2010 |
Samson ML, Kajitani K, Robertson GS. Nitric-oxide synthase mediates the ability of darbepoetin alfa to attenuate pre-existing spatial working memory deficits in rats subjected to transient global ischemia. The Journal of Pharmacology and Experimental Therapeutics. 333: 437-44. PMID 20167842 DOI: 10.1124/Jpet.110.165530 |
0.304 |
|
| 2010 |
Wang J, Menchenton T, Yin S, Yu Z, Bance M, Morris DP, Moore CS, Korneluk RG, Robertson GS. Over-expression of X-linked inhibitor of apoptosis protein slows presbycusis in C57BL/6J mice. Neurobiology of Aging. 31: 1238-49. PMID 18755525 DOI: 10.1016/J.Neurobiolaging.2008.07.016 |
0.714 |
|
| 2009 |
Thorne M, Moore CS, Robertson GS. Lack of TIMP-1 increases severity of experimental autoimmune encephalomyelitis: Effects of darbepoetin alfa on TIMP-1 null and wild-type mice. Journal of Neuroimmunology. 211: 92-100. PMID 19428125 DOI: 10.1016/J.Jneuroim.2009.04.003 |
0.723 |
|
| 2009 |
Alirezaei M, Fox HS, Flynn CT, Moore CS, Hebb AL, Frausto RF, Bhan V, Kiosses WB, Whitton JL, Robertson GS, Crocker SJ. Elevated ATG5 expression in autoimmune demyelination and multiple sclerosis. Autophagy. 5: 152-8. PMID 19066443 DOI: 10.4161/Auto.5.2.7348 |
0.761 |
|
| 2008 |
Moore CS, Hebb AL, Blanchard MM, Crocker CE, Liston P, Korneluk RG, Robertson GS. Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE). Journal of Neuroimmunology. 203: 79-93. PMID 18687476 DOI: 10.1016/J.Jneuroim.2008.06.030 |
0.745 |
|
| 2008 |
Cowper-Smith CD, Anger GJ, Magal E, Norman MH, Robertson GS. Delayed administration of a potent cyclin dependent kinase and glycogen synthase kinase 3 beta inhibitor produces long-term neuroprotection in a hypoxia-ischemia model of brain injury. Neuroscience. 155: 864-75. PMID 18640243 DOI: 10.1016/J.Neuroscience.2008.05.051 |
0.337 |
|
| 2008 |
Hebb AL, Moore CS, Bhan V, Campbell T, Fisk JD, Robertson HA, Thorne M, Lacasse E, Holcik M, Gillard J, Crocker SJ, Robertson GS. Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination. Multiple Sclerosis (Houndmills, Basingstoke, England). 14: 577-94. PMID 18566024 DOI: 10.1177/1352458507087468 |
0.779 |
|
| 2008 |
Hebb AL, Moore CS, Bhan V, Robertson GS. Targeting apoptosis to treat multiple sclerosis. Current Drug Discovery Technologies. 5: 75-7. PMID 18537570 DOI: 10.2174/157016308783769432 |
0.724 |
|
| 2008 |
Moore CS, Hebb AL, Robertson GS. Inhibitor of apoptosis protein (IAP) profiling in experimental autoimmune encephalomyelitis (EAE) implicates increased XIAP in T lymphocytes. Journal of Neuroimmunology. 193: 94-105. PMID 18055022 DOI: 10.1016/J.Jneuroim.2007.10.022 |
0.749 |
|
| 2007 |
Zehntner SP, Bourbonnière L, Moore CS, Morris SJ, Methot D, St Jean M, Lacasse E, Hebb AL, Robertson GS, Durkin J, Gillard JW, Owens T. X-linked inhibitor of apoptosis regulates T cell effector function. Journal of Immunology (Baltimore, Md. : 1950). 179: 7553-60. PMID 18025200 DOI: 10.4049/Jimmunol.179.11.7553 |
0.74 |
|
| 2006 |
Bureau Y, Handa M, Zhu Y, Laliberte F, Moore CS, Liu S, Huang Z, MacDonald D, Xu DG, Robertson GS. Neuroanatomical and pharmacological assessment of Fos expression induced in the rat brain by the phosphodiesterase-4 inhibitor 6-(4-pyridylmethyl)-8-(3-nitrophenyl) quinoline. Neuropharmacology. 51: 974-85. PMID 16901513 DOI: 10.1016/J.Neuropharm.2006.06.018 |
0.329 |
|
| 2006 |
Moore CS, Earl N, Frenette R, Styhler A, Mancini JA, Nicholson DW, Hebb AL, Owens T, Robertson GS. Peripheral phosphodiesterase 4 inhibition produced by 4-[2-(3,4-Bis-difluoromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]-3-methylpyridine-1-oxide (L-826,141) prevents experimental autoimmune encephalomyelitis. The Journal of Pharmacology and Experimental Therapeutics. 319: 63-72. PMID 16809479 DOI: 10.1124/Jpet.106.106096 |
0.704 |
|
| 2006 |
Powell KJ, Binder TL, Hori S, Nakabeppu Y, Weinberger DR, Lipska BK, Robertson GS. Neonatal ventral hippocampal lesions produce an elevation of DeltaFosB-like protein(s) in the rodent neocortex. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 700-11. PMID 16132062 DOI: 10.1038/Sj.Npp.1300883 |
0.339 |
|
| 2004 |
Ayala-Grosso C, Tam J, Xanthoudakis S, Bureau Y, Roy S, Nicholson DW, Robertson GS. Effects of fimbria-fornix transection on calpain and choline acetyl transferase activities in the septohippocampal pathway. Neuroscience. 126: 927-40. PMID 15207327 DOI: 10.1016/J.Neuroscience.2004.04.048 |
0.384 |
|
| 2004 |
Toulmond S, Tang K, Bureau Y, Ashdown H, Degen S, O'Donnell R, Tam J, Han Y, Colucci J, Giroux A, Zhu Y, Boucher M, Pikounis B, Xanthoudakis S, Roy S, ... ... Robertson GS, et al. Neuroprotective effects of M826, a reversible caspase-3 inhibitor, in the rat malonate model of Huntington's disease. British Journal of Pharmacology. 141: 689-97. PMID 14744804 DOI: 10.1038/Sj.Bjp.0705662 |
0.371 |
|
| 2003 |
Crocker SJ, Smith PD, Jackson-Lewis V, Lamba WR, Hayley SP, Grimm E, Callaghan SM, Slack RS, Melloni E, Przedborski S, Robertson GS, Anisman H, Merali Z, Park DS. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 4081-91. PMID 12764095 DOI: 10.1523/Jneurosci.23-10-04081.2003 |
0.788 |
|
| 2003 |
Crocker SJ, Liston P, Anisman H, Lee CJ, Smith PD, Earl N, Thompson CS, Park DS, Korneluk RG, Robertson GS. Attenuation of MPTP-induced neurotoxicity and behavioural impairment in NSE-XIAP transgenic mice. Neurobiology of Disease. 12: 150-61. PMID 12667469 DOI: 10.1016/S0969-9961(02)00020-7 |
0.799 |
|
| 2003 |
McPhail LT, Vanderluit JL, McBride CB, Oschipok LW, Crocker SJ, Xu D, Thompson CS, Liston P, Holcik M, Robertson GS, Tetzlaff W. Endogenous expression of inhibitor of apoptosis proteins in facial motoneurons of neonatal and adult rats following axotomy. Neuroscience. 117: 567-75. PMID 12617963 DOI: 10.1016/S0306-4522(02)00742-X |
0.771 |
|
| 2002 |
Ayala-Grosso C, Ng G, Roy S, Robertson GS. Caspase-cleaved amyloid precursor protein in Alzheimer's disease. Brain Pathology (Zurich, Switzerland). 12: 430-41. PMID 12408229 DOI: 10.1111/J.1750-3639.2002.Tb00460.X |
0.31 |
|
| 2002 |
Davoli MA, Fourtounis J, Tam J, Xanthoudakis S, Nicholson D, Robertson GS, Ng GY, Xu D. Immunohistochemical and biochemical assessment of caspase-3 activation and DNA fragmentation following transient focal ischemia in the rat. Neuroscience. 115: 125-36. PMID 12401327 DOI: 10.1016/S0306-4522(02)00376-7 |
0.366 |
|
| 2002 |
Hu XT, Koeltzow TE, Cooper DC, Robertson GS, White FJ, Vezina P. Repeated ventral tegmental area amphetamine administration alters dopamine D1 receptor signaling in the nucleus accumbens. Synapse (New York, N.Y.). 45: 159-70. PMID 12112395 DOI: 10.1002/Syn.10095 |
0.352 |
|
| 2002 |
Davoli MA, Ren Y, Zhu Y, Fourtounis J, Jones C, Robertson GS, Ng GY, Xu D. Automated analysis of global ischemia-induced CA1 neuronal death using terminal UTP nick end labeling (TUNEL). Journal of Neuroscience Methods. 115: 55-61. PMID 11897363 DOI: 10.1016/S0165-0270(01)00531-3 |
0.347 |
|
| 2001 |
Hutchison JS, Derrane RE, Johnston DL, Gendron N, Barnes D, Fliss H, King WJ, Rasquinha I, MacManus J, Robertson GS, MacKenzie AE. Neuronal apoptosis inhibitory protein expression after traumatic brain injury in the mouse. Journal of Neurotrauma. 18: 1333-47. PMID 11780864 DOI: 10.1089/08977150152725632 |
0.406 |
|
| 2001 |
Lamontagne S, Meadows E, Luk P, Normandin D, Muise E, Boulet L, Pon DJ, Robichaud A, Robertson GS, Metters KM, Nantel F. Localization of phosphodiesterase-4 isoforms in the medulla and nodose ganglion of the squirrel monkey. Brain Research. 920: 84-96. PMID 11716814 DOI: 10.1016/S0006-8993(01)03023-2 |
0.356 |
|
| 2001 |
Crocker SJ, Wigle N, Liston P, Thompson CS, Lee CJ, Xu D, Roy S, Nicholson DW, Park DS, MacKenzie A, Korneluk RG, Robertson GS. NAIP protects the nigrostriatal dopamine pathway in an intrastriatal 6-OHDA rat model of Parkinson's disease. The European Journal of Neuroscience. 14: 391-400. PMID 11553289 DOI: 10.1046/J.0953-816X.2001.01653.X |
0.798 |
|
| 2001 |
Simpson MT, MacLaurin JG, Xu D, Ferguson KL, Vanderluit JL, Davoli MA, Roy S, Nicholson DW, Robertson GS, Park DS, Slack RS. Caspase 3 deficiency rescues peripheral nervous system defect in retinoblastoma nullizygous mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 7089-98. PMID 11549719 DOI: 10.1523/Jneurosci.21-18-07089.2001 |
0.565 |
|
| 2001 |
Simpson MTW, MacLaurin JG, Xu D, Ferguson KL, Vanderluit JL, Davoli MA, Roy S, Nicholson DW, Robertson GS, Park DS, Slack RS. Caspase 3 Deficiency Rescues Peripheral Nervous System Defect in Retinoblastoma Nullizygous Mice The Journal of Neuroscience. 21: 7089-7098. DOI: 10.1523/JNEUROSCI.21-18-07089.2001 |
0.416 |
|
| 2000 |
Calon F, Hadj Tahar A, Blanchet PJ, Morissette M, Grondin R, Goulet M, Doucet JP, Robertson GS, Nestler E, Di Paolo T, Bédard PJ. Dopamine-receptor stimulation: biobehavioral and biochemical consequences. Trends in Neurosciences. 23: S92-100. PMID 11052226 DOI: 10.1016/S1471-1931(00)00026-4 |
0.344 |
|
| 2000 |
Vanderluit JL, McPhail LT, Fernandes KJ, McBride CB, Huguenot C, Roy S, Robertson GS, Nicholson DW, Tetzlaff W. Caspase-3 is activated following axotomy of neonatal facial motoneurons and caspase-3 gene deletion delays axotomy-induced cell death in rodents. The European Journal of Neuroscience. 12: 3469-80. PMID 11029616 DOI: 10.1046/J.1460-9568.2000.00241.X |
0.381 |
|
| 2000 |
Keramaris E, Stefanis L, MacLaurin J, Harada N, Takaku K, Ishikawa T, Taketo MM, Robertson GS, Nicholson DW, Slack RS, Park DS. Involvement of caspase 3 in apoptotic death of cortical neurons evoked by DNA damage. Molecular and Cellular Neurosciences. 15: 368-79. PMID 10845773 DOI: 10.1006/Mcne.2000.0838 |
0.555 |
|
| 2000 |
Giovanni A, Keramaris E, Morris EJ, Hou ST, O'Hare M, Dyson N, Robertson GS, Slack RS, Park DS. E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3. The Journal of Biological Chemistry. 275: 11553-60. PMID 10766769 DOI: 10.1074/Jbc.275.16.11553 |
0.56 |
|
| 2000 |
Robertson GS, Crocker SJ, Nicholson DW, Schulz JB. Neuroprotection by the inhibition of apoptosis. Brain Pathology (Zurich, Switzerland). 10: 283-92. PMID 10764048 DOI: 10.1111/J.1750-3639.2000.Tb00262.X |
0.774 |
|
| 1999 |
Cregan SP, MacLaurin JG, Craig CG, Robertson GS, Nicholson DW, Park DS, Slack RS. Bax-dependent caspase-3 activation is a key determinant in p53-induced apoptosis in neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 7860-9. PMID 10479688 DOI: 10.1523/Jneurosci.19-18-07860.1999 |
0.565 |
|
| 1999 |
Xu D, Bureau Y, McIntyre DC, Nicholson DW, Liston P, Zhu Y, Fong WG, Crocker SJ, Korneluk RG, Robertson GS. Attenuation of ischemia-induced cellular and behavioral deficits by X chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 5026-33. PMID 10366635 DOI: 10.1523/Jneurosci.19-12-05026.1999 |
0.769 |
|
| 1999 |
Gervais FG, Xu D, Robertson GS, Vaillancourt JP, Zhu Y, Huang J, LeBlanc A, Smith D, Rigby M, Shearman MS, Clarke EE, Zheng H, Van Der Ploeg LH, Ruffolo SC, Thornberry NA, et al. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell. 97: 395-406. PMID 10319819 DOI: 10.1016/S0092-8674(00)80748-5 |
0.31 |
|
| 1999 |
Simons M, Beinroth S, Gleichmann M, Liston P, Korneluk RG, MacKenzie AE, Bähr M, Klockgether T, Robertson GS, Weller M, Schulz JB. Adenovirus-mediated gene transfer of inhibitors of apoptosis protein delays apoptosis in cerebellar granule neurons. Journal of Neurochemistry. 72: 292-301. PMID 9886081 DOI: 10.1046/J.1471-4159.1999.0720292.X |
0.446 |
|
| 1999 |
Cregan SP, MacLaurin JG, Craig CG, Robertson GS, Nicholson DW, Park DS, Slack RS. Bax-Dependent Caspase-3 Activation Is a Key Determinant in p53-Induced Apoptosis in Neurons The Journal of Neuroscience. 19: 7860-7869. DOI: 10.1523/JNEUROSCI.19-18-07860.1999 |
0.487 |
|
| 1998 |
Tu Y, Hou ST, Huang Z, Robertson GS, MacManus JP. Increased Mdm2 expression in rat brain after transient middle cerebral artery occlusion. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 18: 658-69. PMID 9626190 DOI: 10.1097/00004647-199806000-00008 |
0.365 |
|
| 1998 |
McGahan L, Hakim AM, Nakabeppu Y, Robertson GS. Ischemia-induced CA1 neuronal death is preceded by elevated FosB and Jun expression and reduced NGFI-A and JunB levels. Brain Research. Molecular Brain Research. 56: 146-61. PMID 9602101 DOI: 10.1016/S0169-328X(98)00039-4 |
0.358 |
|
| 1998 |
McGahan L, Hakim AM, Robertson GS. Hippocampal Myc and p53 expression following transient global ischemia. Brain Research. Molecular Brain Research. 56: 133-45. PMID 9602097 DOI: 10.1016/S0169-328X(98)00038-2 |
0.372 |
|
| 1998 |
Hazell AS, McGahan L, Tetzlaff W, Bedard AM, Robertson GS, Nakabeppu Y, Hakim AM. Immediate-early gene expression in the brain of the thiamine-deficient rat. Journal of Molecular Neuroscience : Mn. 10: 1-15. PMID 9589366 DOI: 10.1007/Bf02737081 |
0.379 |
|
| 1998 |
Crocker SJ, Morelli M, Wigle N, Nakabeppu Y, Robertson GS. D1-Receptor-related priming is attenuated by antisense-meditated 'knockdown' of fosB expression. Brain Research. Molecular Brain Research. 53: 69-77. PMID 9473593 DOI: 10.1016/S0169-328X(97)00281-7 |
0.76 |
|
| 1998 |
Johnston DL, Hutchison JS, King WJ, Derrane RE, Robertson GS, MacKenzie AE. Apoptosis of White Matter Cells Following Traumatic Brain Injury in the Mouse• 204 Pediatric Research. 43: 37-37. DOI: 10.1203/00006450-199804001-00225 |
0.364 |
|
| 1997 |
Budzikowski AS, Vahid-Ansari F, Robertson GS, Leenen FH. Patterns of neuronal activation during development of sodium sensitive hypertension in SHR. Hypertension. 30: 1572-7. PMID 9403585 DOI: 10.1161/01.Hyp.30.6.1572 |
0.314 |
|
| 1997 |
Xu DG, Crocker SJ, Doucet JP, St-Jean M, Tamai K, Hakim AM, Ikeda JE, Liston P, Thompson CS, Korneluk RG, MacKenzie A, Robertson GS. Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus. Nature Medicine. 3: 997-1004. PMID 9288726 DOI: 10.1038/Nm0997-997 |
0.764 |
|
| 1997 |
Xu DG, Korneluk RG, Tamai K, Wigle N, Hakim A, Mackenzie A, Robertson GS. Distribution of neuronal apoptosis inhibitory protein-like immunoreactivity in the rat central nervous system. The Journal of Comparative Neurology. 382: 247-59. PMID 9183692 DOI: 10.1002/(Sici)1096-9861(19970602)382:2<247::Aid-Cne8>3.0.Co;2-3 |
0.382 |
|
| 1997 |
Korneluk RG, MacKenzie AE, Robertson GS. Inhibition of apoptosis proteins (IAPs) and neurodegenerative disease Biochemistry and Cell Biology. 75: 471. DOI: 10.1139/Abstract18 |
0.346 |
|
| 1996 |
Vahid-Ansari F, Robertson GS. 7-OH-DPAT differentially reverses clozapine- and haloperidol-induced increases in Fos-like immunoreactivity in the rodent forebrain. The European Journal of Neuroscience. 8: 2605-11. PMID 8996810 DOI: 10.1111/J.1460-9568.1996.Tb01555.X |
0.383 |
|
| 1996 |
Robertson GS, Fibiger HC. Effects of olanzapine on regional C-Fos expression in rat forebrain. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 14: 105-110. PMID 8822533 DOI: 10.1016/0893-133X(95)00196-K |
0.542 |
|
| 1996 |
Vahid-Ansari F, Nakabeppu Y, Robertson GS. Contrasting effects of chronic clozapine, Seroquel(TM) (ICI 204,636) and haloperidol administration of deltaFosB-like immunoreactivity in the rodent forebrain. The European Journal of Neuroscience. 8: 927-36. PMID 8743740 DOI: 10.1111/J.1460-9568.1996.Tb01579.X |
0.338 |
|
| 1996 |
Doucet JP, Nakabeppu Y, Bedard PJ, Hope BT, Nestler EJ, Jasmin BJ, Chen JS, Iadarola MJ, St-Jean M, Wigle N, Blanchet P, Grondin R, Robertson GS. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum. The European Journal of Neuroscience. 8: 365-81. PMID 8714707 DOI: 10.1111/J.1460-9568.1996.Tb01220.X |
0.415 |
|
| 1995 |
Robertson GS, Jian M. D1 and D2 dopamine receptors differentially increase Fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain. Neuroscience. 64: 1019-34. PMID 7753373 DOI: 10.1016/0306-4522(94)00426-6 |
0.362 |
|
| 1995 |
Robertson GS, Tetzlaff W, Bedard A, St-Jean M, Wigle N. C-fos mediates antipsychotic-induced neurotensin gene expression in the rodent striatum. Neuroscience. 67: 325-44. PMID 7675173 DOI: 10.1016/0306-4522(95)00049-O |
0.362 |
|
| 1994 |
Robertson GS, Matsumura H, Fibiger HC. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. The Journal of Pharmacology and Experimental Therapeutics. 271: 1058-66. PMID 7965768 |
0.435 |
|
| 1994 |
Robertson GS, Staines WA. D1 dopamine receptor agonist-induced Fos-like immunoreactivity occurs in basal forebrain and mesopontine tegmentum cholinergic neurons and striatal neurons immunoreactive for neuropeptide Y. Neuroscience. 59: 375-87. PMID 7911982 DOI: 10.1016/0306-4522(94)90603-3 |
0.407 |
|
| 1993 |
Robertson GS, Tham CS, Wilson C, Jakubovic A, Fibiger HC. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release. The Journal of Pharmacology and Experimental Therapeutics. 264: 1344-51. PMID 8095550 |
0.436 |
|
| 1993 |
Jian M, Staines WA, Iadarola MJ, Robertson GS. Destruction of the nigrostriatal pathway increases Fos-like immunoreactivity predominantly in striatopallidal neurons. Brain Research. Molecular Brain Research. 19: 156-60. PMID 7689681 DOI: 10.1016/0169-328X(93)90161-H |
0.394 |
|
| 1993 |
Fibiger HC, Robertson GS, Guo N. How do atypical antipsychotics work - clues from c-fos studies European Neuropsychopharmacology. 3: 236-237. DOI: 10.1016/0924-977X(93)90047-P |
0.382 |
|
| 1992 |
Brown EE, Robertson GS, Fibiger HC. Evidence for conditional neuronal activation following exposure to a cocaine-paired environment: role of forebrain limbic structures. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 12: 4112-21. PMID 1403102 DOI: 10.1523/Jneurosci.12-10-04112.1992 |
0.42 |
|
| 1992 |
Guo N, Robertson GS, Fibiger HC. Scopolamine attenuates haloperidol-induced c-fos expression in the striatum. Brain Research. 588: 164-7. PMID 1393566 DOI: 10.1016/0006-8993(92)91358-L |
0.509 |
|
| 1992 |
Robertson GS, Vincent SR, Fibiger HC. D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience. 49: 285-96. PMID 1359451 DOI: 10.1016/0306-4522(92)90096-K |
0.511 |
|
| 1992 |
Robertson GS, Hubert GW, Tham CS, Fibiger HC. Lesions of the mesotelencephalic dopamine system enhance the effects of selective dopamine D1 and D2 receptor agonists on striatal acetylcholine release. European Journal of Pharmacology. 219: 323-5. PMID 1358643 DOI: 10.1016/0014-2999(92)90313-S |
0.459 |
|
| 1992 |
Robertson GS, Fibiger HC. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience. 46: 315-28. PMID 1347406 DOI: 10.1016/0306-4522(92)90054-6 |
0.503 |
|
| 1991 |
Damsma G, Robertson GS, Tham CS, Fibiger HC. Dopaminergic regulation of striatal acetylcholine release: importance of D1 and N-methyl-D-aspartate receptors. The Journal of Pharmacology and Experimental Therapeutics. 259: 1064-72. PMID 1837058 |
0.453 |
|
| 1991 |
Robertson GS, Pfaus JG, Atkinson LJ, Matsumura H, Phillips AG, Fibiger HC. Sexual behavior increases c-fos expression in the forebrain of the male rat. Brain Research. 564: 352-7. PMID 1810635 DOI: 10.1016/0006-8993(91)91477-I |
0.462 |
|
| 1991 |
Robertson GS, Damsma G, Fibiger HC. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 11: 2209-16. PMID 1712381 DOI: 10.1523/Jneurosci.11-07-02209.1991 |
0.462 |
|
| 1991 |
Robertson GS, Fine A, Robertson HA. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats. Brain Research. 539: 304-11. PMID 1675908 DOI: 10.1016/0006-8993(91)91634-D |
0.545 |
|
| 1990 |
Robertson GS, Vincent SR, Fibiger HC. Striatonigral projection neurons contain D1 dopamine receptor-activated c-fos. Brain Research. 523: 288-90. PMID 2144781 DOI: 10.1016/0006-8993(90)91498-6 |
0.497 |
|
| 1990 |
Damsma G, Tham CS, Robertson GS, Fibiger HC. Dopamine D1 receptor stimulation increases striatal acetylcholine release in the rat. European Journal of Pharmacology. 186: 335-8. PMID 1981190 DOI: 10.1016/0014-2999(90)90456-G |
0.441 |
|
| 1990 |
Dragunow M, Robertson GS, Faull RL, Robertson HA, Jansen K. D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience. 37: 287-94. PMID 1966822 DOI: 10.1016/0306-4522(90)90399-O |
0.639 |
|
| 1989 |
Robertson GS, Robertson HA. Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 9: 3326-31. PMID 2795165 DOI: 10.1523/Jneurosci.09-09-03326.1989 |
0.576 |
|
| 1989 |
Robertson HA, Peterson MR, Murphy K, Robertson GS. D1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour. Brain Research. 503: 346-9. PMID 2532558 DOI: 10.1016/0006-8993(89)91689-2 |
0.559 |
|
| 1989 |
Robertson GS, Herrera DG, Dragunow M, Robertson HA. L-dopa activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra. European Journal of Pharmacology. 159: 99-100. PMID 2495972 DOI: 10.1016/0014-2999(89)90049-6 |
0.749 |
|
| 1988 |
Robertson GS, Robertson HA. Evidence that the substantia nigra is a site of action for L-DOPA. Neuroscience Letters. 89: 204-8. PMID 3393296 DOI: 10.1016/0304-3940(88)90382-5 |
0.541 |
|
| 1988 |
Dragunow M, Robertson HA, Robertson GS. Amygdala kindling and c-fos protein(s). Experimental Neurology. 102: 261-3. PMID 3141205 DOI: 10.1016/0014-4886(88)90103-3 |
0.611 |
|
| 1987 |
Robertson HA, Robertson GS. Combined L-dopa and bromocriptine therapy for Parkinson's disease: a proposed mechanism of action. Clinical Neuropharmacology. 10: 384-7. PMID 3503682 |
0.431 |
|
| 1987 |
Robertson GS, Robertson HA. D1 and D2 dopamine agonist synergism: separate sites of action? Trends in Pharmacological Sciences. 8: 295-299. DOI: 10.1016/0165-6147(87)90121-0 |
0.516 |
|
| 1986 |
Robertson GS, Robertson HA. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats. Brain Research. 384: 387-90. PMID 2946360 DOI: 10.1016/0006-8993(86)91178-9 |
0.522 |
|
| Show low-probability matches. |